Clinical Trials

Medical discoveries do not happen by chance. Through clinical trials, doctors and scientists understand how to diagnose, treat, cure or prevent diseases. Taking part in trials not only benefits those you love but it helps future generations and others with the same disease. SERI houses a dedicated research clinic facility to conduct comprehensive clinical trials and research studies.

Find out more

Technologies Available for Licensing

SERI researchers continuously produce inventions and discoveries with market potential, and we look to bring these to market either via licensing or creation of dedicated spin-offs. We are seeking industrial partners to license and commercialize several technologies which are more mature and ready for advanced testing, development and deployment.

Find out more

Research at Myopia Centre We’re on a mission. To create solutions, prevent and treat myopia to stop the rising onset of a global epidemic. Click to learn more!

Research Bulletin SERI has been involved in conducting high-impact eye research since its establishment in 1997, with the aim to prevent blindness, low vision and major eye diseases prevalent in Singaporeans and Asians. Read more about the path-breaking research and insights here.

Research PhD Programmes Research PhD programmes are available in the various institutes. Check them out here.

SERI Junior Overseas Scientist Fellowship The SERI Junior Overseas Scientist Fellowship isdesigned to nurture young scientists in ophthalmology and visual sciences around the world, and to establish collaborative network between them and SERI.

Give to VisionSave

Your generosity will go a long way towards providing financial assistance for needy patients, funding research for better treatments and training the next generation of eye specialists for excellent patient care. Join us in paving the way to a brighter future by making a donation today.

Donate now

Recent News

Announcements S’pore institute in $21m tie-up to develop treatments for eye diseases SERI and Santen has launched SONIC 2.0, a $21 million initiative to develop treatments for eye diseases like glaucoma and myopia. The three-year collaboration builds on SONIC 1.0, which resulted in 13 research projects and the development of low-dose atropine drops for myopia. SONIC 2.0 aims to develop two treatments to the clinical stage, expand the use of ophthalmic drugs and contribute to Singapore's biomedical innovation.

04 Dec 2025 | The Straits Times Read Story

Research Eyes can be windows to early detection of Alzheimer’s disease, Singapore researchers find

08 Jan 2024 | The Straits Times Read Story

Research 本地研究：降血脂药或可修复眼角膜神经损伤

本地研究：降血脂药或可修复眼角膜神经损伤

17 Mar 2023 | Lianhe Zaobao Read Story

View All News